<DOC>
	<DOCNO>NCT00964392</DOCNO>
	<brief_summary>The purpose registry provide additional corroborative short-term safety long-term safety data NAVISTAR THERMOCOOL NAVISTAR EZ STEER THERMOCOOL catheter treatment symptomatic Paroxysmal Atrial Fibrillation ( PAF ) .</brief_summary>
	<brief_title>NAVISTAR® THERMOCOOL® Catheter Radiofrequency Ablation Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation</brief_title>
	<detailed_description>This registry prospective , multi-center , non-randomized post approval evaluation comprise two ( 2 ) registry arm independent hypothesis . The registry arm define ; Arm 1 ) physician perform great equal 50 atrial fibrillation ablation procedure per year Arm 2 ) physician perform less 50 atrial fibrillation ablation procedure per year . Subjects drug refractory recurrent symptomatic PAF consider post approval registry . This registry conduct 40 center minimum 381 evaluable subject . The device currently FDA approve commercial distribution PMA # P030031/S11 .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Candidates registry must meet ALL follow criterion : Patients drug refractory recurrent symptomatic PAF three ( 3 ) AF episodes six ( 6 ) month prior enrollment one AF episode document within one ( 1 ) year prior enrollment . Documentation may include electrocardiogram ( ECG ) , transtelephonic monitor ( TTM ) , Holter monitor ( HM ) , telemetry strip . Failure least one AAD AF ( class I III AV nodal block agent beta blocker calcium channel blocker ) evidence recurrent symptomatic PAF , intolerable side effect . Age 18 year old . Able willing comply pre , post followup testing requirement . Signed Patient Informed Consent Form . Candidates exclude registry follow condition apply : Atrial fibrillation secondary electrolyte imbalance , thyroid disease , reversible noncardiac cause . AF episode last long 30 day terminate via cardioversion . CABG procedure within last six ( 6 ) month . Awaiting cardiac transplantation cardiac surgery . Documented leave atrial thrombus imaging ( i.e. , TEE , ICE , CT , MRA ) . History document thromboembolic event within past one ( 1 ) year . Diagnosed atrial myxoma . Significant congenital anomaly medical problem opinion investigator would preclude enrollment registry . Women pregnant ( history menstrual period pregnancy test history consider unreliable ) . Acute illness active systemic infection sepsis . Unstable angina . Uncontrolled heart failure . Myocardial infarction within previous two ( 2 ) month . History blood clot bleed abnormality . Contraindication anticoagulation ( i.e . heparin warfarin ) . Life expectancy le 12 month . Enrollment investigational study evaluate another device drug . Presence intramural thrombus , tumor abnormality precludes catheter introduction manipulation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>